The crucial role of CD4 CAR T cells was recently pointed out by Melenhorst and colleagues, who observed that CD4+ CAR T cells dominated the CAR T cell population of patients with decade-long leukemia remission at later monitoring time points. The gene discussed is CD4; the disease is leukemia.